Aug 06, 2021 / 08:30AM GMT
Layan Kalisse -
Okay. It looks like we have everyone in the room, and we're ready to kick off.
Sigurdur Oli Olafsson - Hikma Pharmaceuticals PLC - CEO & Executive Director
Thanks, Layan. So we're ready to go. I thought we would just open it straight up for questions and answers. So if you have a question, let us know, and we'd be happy to kick it off.
Questions and Answers:
Layan Kalisse -So this is just going to be the usual setup. (Operator Instructions)
So we already have our first question from Pete Verdult.
Peter Verdult - Citigroup Inc., Research Division - MD
Yes. Peter Verdult, Citi. Two questions. Just firstly, maybe just starting with Branded actually. Great start to the year. You're still saying mid-single-digit growth basically means that you're going to be declining in the second half. I know you talked about some pull-through, but can you just help us understand, is there any sort of upside risks growing Branded versus the guidance, not just near term,
Trustpilot
